Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP678043.RARk-eOUvQqG5nMNawpjOUmTI4O1aivLjremdgKTz_sAA130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678043.RARk-eOUvQqG5nMNawpjOUmTI4O1aivLjremdgKTz_sAA130_provenance.
• NP140696.RADvrp-oY2SNPlXIDw4KD730ogyHAQfyIVtTPsqf72wDU130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP140696.RADvrp-oY2SNPlXIDw4KD730ogyHAQfyIVtTPsqf72wDU130_provenance.
• NP109748.RABf7mKF2je8Gd946KAxRX5wkaWtdruv-czt920bEHgOY130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109748.RABf7mKF2je8Gd946KAxRX5wkaWtdruv-czt920bEHgOY130_provenance.
• NP497461.RAIbUjQzAiZmiXLDhgtI5QsVEYjZGDP4p9FNPUdxAWS2k130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497461.RAIbUjQzAiZmiXLDhgtI5QsVEYjZGDP4p9FNPUdxAWS2k130_provenance.
• NP367719.RAYKDQFA0Fih3lkHhQDkeSwK5kteyp3Cu9pU3_a6PvktA130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367719.RAYKDQFA0Fih3lkHhQDkeSwK5kteyp3Cu9pU3_a6PvktA130_provenance.
• NP367813.RAVM6EL9_Qy_KPa54TIBmDLXJ33vlh5RyAILsAbgGziXs130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367813.RAVM6EL9_Qy_KPa54TIBmDLXJ33vlh5RyAILsAbgGziXs130_provenance.
• NP132739.RA-UgqRezSPq-fdlOjzM-ssajobo1PxqsxNWbeT-bEVnA130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP132739.RA-UgqRezSPq-fdlOjzM-ssajobo1PxqsxNWbeT-bEVnA130_provenance.
• NP132740.RAxTlcl43zUOaCvX7oLEFndR6dmuIwe-u2eOXcAVuV9Qw130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP132740.RAxTlcl43zUOaCvX7oLEFndR6dmuIwe-u2eOXcAVuV9Qw130_provenance.
• NP132741.RA_lNij08QaxTPl4VTV6R0uALZ8TDePfwzBwpp5wz-VqQ130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP132741.RA_lNij08QaxTPl4VTV6R0uALZ8TDePfwzBwpp5wz-VqQ130_provenance.
• NP140693.RA9CUYf-MJycsUykoEzR7EHfyHfcT8CDhSLplLAgz7sbs130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP140693.RA9CUYf-MJycsUykoEzR7EHfyHfcT8CDhSLplLAgz7sbs130_provenance.
• NP140695.RA1fWQaywo3lQucRIEQrKMB4ENxHYvqhHGr0XXChOvbWc130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP140695.RA1fWQaywo3lQucRIEQrKMB4ENxHYvqhHGr0XXChOvbWc130_provenance.
• NP163239.RAD8fK5C106mweUPdtrN6h-DnAVtpxEkQM0eCsBBaFw68130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163239.RAD8fK5C106mweUPdtrN6h-DnAVtpxEkQM0eCsBBaFw68130_provenance.
• assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP132737.RAK7czC8Ia75vbp2ZK6bX1wHU_0q3z5vFDhWDLHeFlFgs130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP132737.RAK7czC8Ia75vbp2ZK6bX1wHU_0q3z5vFDhWDLHeFlFgs130_provenance.
• NP789369.RAwRjIxVGUWKeGf077oEafW6nNgGatTPUdEWXWDNspX_g130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789369.RAwRjIxVGUWKeGf077oEafW6nNgGatTPUdEWXWDNspX_g130_provenance.
• NP163240.RATC-_ClgeQQcZ2hYJl1XP_XIZxiUPxQRjw632rAx5Heo130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163240.RATC-_ClgeQQcZ2hYJl1XP_XIZxiUPxQRjw632rAx5Heo130_provenance.
• NP789366.RAQuNUlp0ssolOSilbmlOzP7xnGCfo-Q-BRBwrVy8xStM130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789366.RAQuNUlp0ssolOSilbmlOzP7xnGCfo-Q-BRBwrVy8xStM130_provenance.
• NP390213.RAKQ9GXolAMpZEZL034qlymV5j5VgSpF6zL-gEFTBk638130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390213.RAKQ9GXolAMpZEZL034qlymV5j5VgSpF6zL-gEFTBk638130_provenance.
• NP132738.RAl7tUlnQA0irOFrcCIH1_359aHBi2er0yiTB7P32uhPY130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP132738.RAl7tUlnQA0irOFrcCIH1_359aHBi2er0yiTB7P32uhPY130_provenance.
• NP109742.RAgRfsnAZ_Swl29PWKgT5LH5rxtB8H9SlUto28LUjyQs8130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109742.RAgRfsnAZ_Swl29PWKgT5LH5rxtB8H9SlUto28LUjyQs8130_provenance.
• assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP163231.RAIg7dpYusCS1SlN6qQnEBB8p23MHy9XNIz0VLO3xyGVM130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163231.RAIg7dpYusCS1SlN6qQnEBB8p23MHy9XNIz0VLO3xyGVM130_provenance.
• NP163233.RAKEWrtHWOjr72zmi0N0uounaY7eRCp1xdbgloyahjRg4130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163233.RAKEWrtHWOjr72zmi0N0uounaY7eRCp1xdbgloyahjRg4130_provenance.
• NP163234.RALf8AL8D_vPWB4EUdMF6LN7tUfKB0p9GSrLB19V71MDE130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163234.RALf8AL8D_vPWB4EUdMF6LN7tUfKB0p9GSrLB19V71MDE130_provenance.
• NP163235.RAGB7pQCDsenha8rmU6CBX07yzLqBclndMcowh8tr5StE130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163235.RAGB7pQCDsenha8rmU6CBX07yzLqBclndMcowh8tr5StE130_provenance.
• NP163236.RAMm7k_RBlQ4yPPaGE6axmVM0R-SHYH4HDSgkWRMZ6dms130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163236.RAMm7k_RBlQ4yPPaGE6axmVM0R-SHYH4HDSgkWRMZ6dms130_provenance.
• NP163238.RAIixB-WTOyUv1NX4ZpcNHu9VnGNE9nOvfePQql4JQJSE130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163238.RAIixB-WTOyUv1NX4ZpcNHu9VnGNE9nOvfePQql4JQJSE130_provenance.
• NP789367.RAMqy1CxlZOgk0_xjUMkwfD207WIWjQ40PAdbBtUbtWJM130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789367.RAMqy1CxlZOgk0_xjUMkwfD207WIWjQ40PAdbBtUbtWJM130_provenance.
• NP390191.RAhqIWM6Nh-xAC8guRVO42KVrcElOmebMwZgBa5md6d3M130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390191.RAhqIWM6Nh-xAC8guRVO42KVrcElOmebMwZgBa5md6d3M130_provenance.
• NP163232.RAok-9Qr_cIEV0M6BUoXlNkjXxnL7S4QvOFthZ25-kl-M130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163232.RAok-9Qr_cIEV0M6BUoXlNkjXxnL7S4QvOFthZ25-kl-M130_provenance.
• NP163237.RAtPqbJdKV6HOB0p_Nc9bqssZ0vSA1omWfz070SfJD0Hk130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163237.RAtPqbJdKV6HOB0p_Nc9bqssZ0vSA1omWfz070SfJD0Hk130_provenance.
• NP789368.RAlGwaqZ6PDFBPBS8Nj3Cte04t2NFdWYAjd28NCosLiX4130_assertion description "[This study supports the role of functional PAR-1 and EGF polymorphisms as independent prognostic markers in localized EA and may therefore help to identify patient subgroups at high risk for tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789368.RAlGwaqZ6PDFBPBS8Nj3Cte04t2NFdWYAjd28NCosLiX4130_provenance.